415 related articles for article (PubMed ID: 8853521)
1. Osteoporosis prevention and treatment: its relevance to breast cancer patients.
Hodsman AB
Can J Oncol; 1995 Dec; 5 Suppl 1():28-32. PubMed ID: 8853521
[TBL] [Abstract][Full Text] [Related]
2. [Osteoporosis--pathogenesis and prophylaxis].
Skrzypulec V; Rozmus-Warcholińska W; Walaszek A; Drosdzol A; Nowosielski K; Piela B
Wiad Lek; 2004; 57 Suppl 1():295-300. PubMed ID: 15884261
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal osteoporosis and hormone replacement therapy.
Gambacciani M; Vacca F
Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
[TBL] [Abstract][Full Text] [Related]
4. Preventing and treating osteoporosis: strategies at the millennium.
Sherman S
Ann N Y Acad Sci; 2001 Dec; 949():188-97. PubMed ID: 11795353
[TBL] [Abstract][Full Text] [Related]
5. [Involutional osteoporosis--pathogenesis, diagnosis, prevention and therapy].
Kuska J; Wiecek A; Czech U
Postepy Hig Med Dosw; 1991; 45(1-2):101-17. PubMed ID: 1923992
[No Abstract] [Full Text] [Related]
6. [Osteoporosis is prevented by physical activity, calcium and hormone supplementation].
Piehl-Aulin K; Brahm H
Lakartidningen; 1999 Jan; 96(3):210-4. PubMed ID: 10068323
[TBL] [Abstract][Full Text] [Related]
7. The different routes of administration and the effect of hormone replacement therapy on osteoporosis.
Christiansen C
Fertil Steril; 1994 Dec; 62(6 Suppl 2):152S-156S. PubMed ID: 7958010
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of osteoporosis and its economic aspects].
Blachier C
Cah Sociol Demogr Med; 1999; 39(2-3):271-82. PubMed ID: 10615567
[TBL] [Abstract][Full Text] [Related]
9. [Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis].
Lamy O; Krieg MA
Rev Med Suisse Romande; 2002 Aug; 122(8):377-81. PubMed ID: 12357730
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal osteoporosis and alendronate.
Pérez-López FR
Maturitas; 2004 Jul; 48(3):179-92. PubMed ID: 15207883
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis. Clinical features, prevention, and treatment.
Gambert SR; Schultz BM; Hamdy RC
Endocrinol Metab Clin North Am; 1995 Jun; 24(2):317-71. PubMed ID: 7656894
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis: strategies for prevention.
Blanchard F; Papapoulos S; Compston J; Maggi S
Aging (Milano); 1998 Apr; 10(2):161-2. PubMed ID: 9666218
[No Abstract] [Full Text] [Related]
13. The treatment of osteoporosis. Antiresorptive therapy.
Miller PD
Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
[TBL] [Abstract][Full Text] [Related]
14. Prevention of osteoporosis and fractures.
Ullom-Minnich P
Am Fam Physician; 1999 Jul; 60(1):194-202. PubMed ID: 10414638
[TBL] [Abstract][Full Text] [Related]
15. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
Ohta H
Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
[TBL] [Abstract][Full Text] [Related]
16. The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer.
Candelaria-Quintana D; Dayao ZR; Royce ME
Breast Cancer Res Treat; 2012 Apr; 132(2):355-63. PubMed ID: 21987034
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of osteoporosis.
Hawker GA
J Rheumatol Suppl; 1996 Aug; 45():2-5. PubMed ID: 8856643
[TBL] [Abstract][Full Text] [Related]
18. Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors.
Clunie GP; Clark A; Mortimer CJ; Stephenson S; Aitken J; Smith C; Sherwin E; Archer TJ
Eur J Surg Oncol; 2009 May; 35(5):475-80. PubMed ID: 18950981
[TBL] [Abstract][Full Text] [Related]
19. [The successful development of bisphosphonates in the therapy of osteoporosis].
Fassbender WJ; Stumpf UC; Kurth A
Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
[TBL] [Abstract][Full Text] [Related]
20. Prevention and treatment of postmenopausal osteoporosis.
Lewiecki EM
Obstet Gynecol Clin North Am; 2008 Jun; 35(2):301-15, ix. PubMed ID: 18486843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
